Piotr Obuch-Woszczatyński
Obuch-Woszczatyński, Piotr.
VIAF ID: 313514409 (Personal)
Permalink: http://viaf.org/viaf/313514409
Preferred Forms
-
-
- 100 0 _ ‡a Piotr Obuch-Woszczatyński
4xx's: Alternate Name Forms (11)
Works
Title | Sources |
---|---|
Antimicrobial effects of Manuka honey on in vitro biofilm formation by Clostridium difficile. | |
Are Rapid Immunoassays for in vivo Detection of Toxin A Sufficient for Diagnostic Purposes of Clostridium difficile -Associated Diseases? | |
[Assessment of antagonistic activity in vitro Lactobacillus spp. strains againts Clostridum difficile strains isolated from gastrointestinal tract of patients hospitalized in three hospitals in region Mazovia]. | |
[Assessment of susceptibility of strictly anaerobic bacteria originated from different sources to fluoroquinolones and other antimicrobial drugs] | |
Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002 | |
Assessment of the usefulness of chromogenic medium for the isolation of Clostridium difficile from the gastrointestinal tract of children with diarrhoea | |
Badanie aktywności enzymatycznej szczepów Candida izolowanych z materiałów klinicznych chorych z układową kandydozą | |
Clindamycin-resistant, toxin A-negative, toxin B-positive Clostridium difficile strains cause antibiotic-associated diarrhea among children hospitalized in a hematology unit | |
Clostridium Perfringens jako czynnik etiologiczny biegunki poantybiotykowej | |
[Comparative study of thermoresistance spores of Clostridium difficile strains belonging to different toxigenicity groups] | |
Detection of binary-toxin genes | |
[Detection of ermB gene responsible for high level resistance to clindamycin | |
Enterotoxigenic Bacteroides fragilis (ETBF) strains isolated in the Netherlands and Poland are genetically diverse | |
Enterotoxigenic Clostridium perfringens infection and pediatric patients with inflammatory bowel disease. | |
Enterotoxin-producing Bacteroides fragilis (ETBF) Strains in Stool Samples Submitted for Testing ofClostridium difficile and its Toxins | |
Enzymatyczna zmienność Candida krusei w przebiegu zakażenia grzybiczego u biorcy wątroby | |
First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland | |
Fructooligosaccharides and mannose affect Clostridium difficile adhesion and biofilm formation in a concentration-dependent manner | |
The level of fecal calprotectin significantly correlates with Clostridium difficile infection severity | |
Nawracające zakażenie Clostridium difficiele u dzieci z nieswoistymi zapaleniami jelit | |
Nowe perspektywy w leczeniu i profilaktyce zakażeń Clostridium difficile = New perspectives for treatment and prevention of Clostridium difficile infection | |
Ocena przydatności podłoża chromogennego do izolacji Clostridium difficile z przewodu pokarmowego dzieci z biegunką | |
Ocena wrażliwości szczepów bezwzględnych beztlenowców pochodzących z różnych źródeł na fluorochinolony oraz inne leki stosowane w lecznictwie szpitalnym | |
Prevalence of Clostridium difficile infection in hospitalized patients with diarrhoea: Results of a Polish multicenter, prospective, biannual point-prevalence study. | |
[Profile of toxigenicity of Clostridium difficile strains isolated from paediatric patients with clinical diagnosis of antibiotic associated diarrhea (AAD)] | |
Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland | |
Variable flagella expression among clonal toxin A−/B+ Clostridium difficile strains with highly homogeneous flagellin genes | |
Występowanie Clostridium difficile w przewodzie pokarmowym hospitalizowanych dzieci do drugiego roku życia |